RecallDepth
Class II Terminated

Nystatin Oral Suspension, USP 100,000 units per mL, Cherry/Peppermint Flavor, Rx ONLY, packaged in a) 16 fl oz (473 mL) NDC 0121-0868-16; b) 2 fl oz (60 mL) NDC 0121-0868-02; Manufactured by: Pharmaceutical Associates, Inc. Greenville, SC 29605

This recall has been terminated (originally issued August 18, 2021).

Company
Pai Holdings, Llc. Dba Pharmaceutical Associates Inc
Recall Initiated
July 29, 2021
Posted
August 18, 2021
Recall Number
D-0721-2021
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
a) 1002 cases (12 bottles/case); b) 458 cases (24 bottles/case)
Firm Location
Greenville, SC, United States
Official Source
View on FDA website ↗

Reason for Recall

Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.

Distribution

Distributed Nationwide in the USA

Lot / Code Info

Lots: a) C98F, C990 Exp. 30SEP2022, C9C2 Exp. 31OCT2022; b) C9E1 Exp. 31OCT2022

More recalls by Pai Holdings, Llc. Dba Pharmaceutical Associates Inc

View all recalls by this company →

Other recent Class II Drug recalls